ASTRAZENECA DRN forum
AZN flying to level of butterfly target
AZN Crossed over 200EMA, and coming out from a daily negative trend channel.Interesting indeed.
AZN developing capivasertib (triple negative breast cancer) and AZD3252 (Covid) both phase 3 trials expected to be complete by end of June 2024.
AZN long position 1D
AZN long position 15m
